At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 16 enrolled
Drug / intervention
TRS01 eye drops +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Masked, Dose-Ranging Study to Evaluate the Safety and Tolerability of TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis.
In Brief
A Phase 2 clinical trial evaluating TRS01 eye drops for Non-infectious Anterior Uveitis. Completed, enrolled 16 participants across 2 sites.
Detailed Summary
The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis .
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-infectious Anterior Uveitis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartFeb 2020
Primary CompletionAug 2020
TodayJul 2026
First PostedJan 10, 2020
Enrollment StartFeb 1, 2020
Primary CompletionAug 24, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.5 years ago
Interventions
TRS01 eye dropsdrug
Dosed four times a day (QID)
TRS01 eye dropsdrug
Dosed four times a day (QID)